Urogen Pharma Ltd (NASDAQ:URGN)
| 9.75 Delayed Data As of Jun 02 |  -0.02 / -0.20%Today’s Change | 5.14 Today|||52-Week Range 16.11 | +9.92% Year-to-Date |
Latest URGN News | Press Releases
No recent news for Urogen Pharma Ltd.
Today’s Trading
| Previous close | 9.77 |
| Today’s open | 9.87 |
| Day’s range | 9.70 - 9.96 |
| Volume | 5,698 |
| Average volume (3 months) | 161,214 |
| Market cap | $228.7M |
Data as of 3:59pm ET, 06/02/2023
Growth & Valuation
| Earnings growth (last year) | +2.93% |
| Earnings growth (this year) | +12.70% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +33.96% |
| P/E ratio | NM |
| Price/Sales | 3.14 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IFRXInflaRx NV | -0.08 | -1.86% |
| ACETAdicet Bio Inc | +0.17 | +3.18% |
| LCTXLineage Cell Therape... | +0.05 | +3.91% |
| CRMDCorMedix Inc | +0.16 | +3.21% |
Data as of 3:59pm ET, 06/02/2023
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$1.07 |
| Annual revenue (last year) | $64.4M |
| Annual profit (last year) | -$109.8M |
| Net profit margin | -170.58% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Princeton, New Jersey |
Forecasts
